Health
US vaccine firm: Human trials could be held in Israel as infection rates rise – The Times of Israel
After Jerusalem signed binding term sheet for purchase of drug, CEO of Arcturus Therapeutics says Phase 3 study needs to be held in location with substantial number of cases
The head of a US firm developing a COVID-19 vaccine said Sunday that as infection rates of the coronavirus rise in Israel, it could be used as a location for human trials.
“My understanding is that Israel is under some significant challenges with respect to the prevalence of COVID, and it would present an opportunity to perhaps do the registration study in Israel, combining that data with other countries as well,” Arcturus Therapeutics CEO Joseph Payne told Channel 12 news, referring to the Pha…
-
Noosa News21 hours agoBondi Beach terror attack: Police investigate threat against Westfield North Lakes in Queensland
-
Noosa News22 hours agoBrand update as firm marks 25 years – Proctor
-
Noosa News22 hours agoNon-compliance, human error led to $2m Noosa Council fraud
-
General22 hours agoSea search for missing Victorian man off Cape Jaffa ends